Janrain tapped to develop and implement critical digital identity management technology standards for the life sciences industry July 13, 2017 by Bryta Schulz Align Biopharma, biopharma, digital healthcare, HCPs, pharma Janrain has joined Align BiopharmaTM, an industry technology standards group that includes 23 leading biopharma companies and technology and service providers. The group is creating and implementing open technology standards that make it easier for healthcare professionals (HCPs) to connect digitally with life sciences companies. We at Janrain have a rich legacy of providing customer-driven identity management platforms for global pharma companies, such as Eli Lilly and Company, Pfizer and Merck. Each new drug introduced to the market comes with a great deal of tailored information required by doctors. Healthcare professionals have had difficulty accessing and establishing the true source of this information due to the complexity of navigating the multitude of digital content and channels. In response to this, Align Biopharma has defined an identification and authentication standard that enables single sign-on for HCPs to access online content—including websites, portals, virtual events or webinars—directly from the life sciences companies. Align Biopharma members are joining forces to define the standards for consent and preference management so that there is consistency in how HCPs specify communication preferences with each company—an essential component for companies that do business in the EU and must comply with the General Data Protection Regulation (GDPR) scheduled to go into effect in May of 2018. At Janrain, we began investing in the pharma category in 2010 and now work with a majority of the top 10 pharmaceutical companies globally. Our excitement around Align Biopharma is rooted in our passion to innovate in digital identity, as well as in our passion to collaborate and share those innovations with the identity industry. Janrain’s commitment to open standards began when we helped form the OpenID foundation. We’re very eager to contribute our pharma learnings from over the past seven years and to help advance not only the HCP’s experiences, but patients’ experiences and our client organizations’ experiences. Furthermore Janrain led the pack amongst identity management providers to achieve HIPAA/HITECH-certification. We believe that having a strong standardized identity solution will facilitate compliance and simultaneously enhance personalization capabilities. I read a stat in Bio-IT World that stated life science companies have to manage 60-70 digital entry points for their products and services: a host of websites, portals, and mobile apps all sharing information with users. That’s pretty complex. The user experience will be greatly simplified with this new industry standard so that companies can provide more personalized services that are tailored for individual needs.